1-Benzhydryl-4-cinnamylpiperazine

Catalog No. :
ACSHGA671
CAS No. :
298-57-7
Molecular Formula :
C26H28N2
Molecular Weight :
368.52

IUPAC Name:1-benzhydryl-4-(3-phenylallyl)piperazine

1-Benzhydryl-4-cinnamylpiperazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Benzhydryl-4-cinnamylpiperazine
IUPAC Name1-benzhydryl-4-(3-phenylallyl)piperazine
MDL No.MFCD00056037
Molecular FormulaC26H28N2
Molecular Weight368.52
SMILESN1(C(C2=CC=CC=C2)C3=CC=CC=C3)CCN(CC=CC4=CC=CC=C4)CC1
InChI KeyDERZBLKQOCDDDZ-UHFFFAOYSA-N
SynonymArtate | BPBio1_000172 | Cinnarizinum | Votegol | (E)-1-Benzhydryl-4-cinnamylpiperazine | cinnarizine | Folcodal | R 1575 | 516 MD | Aplexal | CINNARIZINE [MART.] | Sedatromin | Lopac0_000314 | Siptazin | UNII-3DI2E1X18L | DTXCID802821 | R-1575 | BSPBio_0
CAS No.298-57-7
PubChem CID1547484

Safety Data

Pictogram
Harmful or irritantHealth hazardEnvironmental hazard
Signal Word
Gefahr
Hazard Statement(s)
H302-H319-H372-H410
Precautionary Statement(s)
P260-P264-P270-P273-P280-P301+P312+P330-P305+P351+P338-P314-P337+P313-P391-P501

Synthetic Route by SureRoute

1. ACSHGA671 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACZKTD947 route compound structure diagram
    ACZKTD9471135-40-6 In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACSHGA671 route product structure diagram
    ACSHGA671298-57-7
Inquiry

2. ACSHGA671 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACONZR821 route compound structure diagram
    ACONZR821841-77-0 In Stock
  4. Then
  5. ACSHGA671 route product structure diagram
    ACSHGA671298-57-7
Inquiry

Comments (0)